COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - US19459J1043 - Common Stock
38.35 USD
-0.44 (-1.13%)
38.35 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 193 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
COLL had a positive operating cash flow in the past year.
Of the past 5 years COLL 4 years were profitable.
COLL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
COLL has a better Return On Assets (2.28%) than 83.94% of its industry peers.
COLL has a Return On Equity of 15.62%. This is amongst the best in the industry. COLL outperforms 89.12% of its industry peers.
With an excellent Return On Invested Capital value of 7.69%, COLL belongs to the best of the industry, outperforming 83.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COLL is below the industry average of 15.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROIC | 7.69% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
Looking at the Profit Margin, with a value of 5.13%, COLL belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
COLL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.35%, COLL belongs to the top of the industry, outperforming 87.05% of the companies in the same industry.
In the last couple of years the Operating Margin of COLL has grown nicely.
With a decent Gross Margin value of 56.69%, COLL is doing good in the industry, outperforming 66.32% of the companies in the same industry.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
The number of shares outstanding for COLL has been reduced compared to 1 year ago.
Compared to 5 years ago, COLL has less shares outstanding
Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
COLL has an Altman-Z score of 1.18. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
COLL has a Altman-Z score of 1.18. This is comparable to the rest of the industry: COLL outperforms 59.59% of its industry peers.
The Debt to FCF ratio of COLL is 4.08, which is a neutral value as it means it would take COLL, 4.08 years of fcf income to pay off all of its debts.
COLL has a better Debt to FCF ratio (4.08) than 86.53% of its industry peers.
COLL has a Debt/Equity ratio of 3.27. This is a high value indicating a heavy dependency on external financing.
COLL has a worse Debt to Equity ratio (3.27) than 79.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 1.18 |
ROIC/WACC0.79
WACC9.71%
2.3 Liquidity
A Current Ratio of 1.18 indicates that COLL should not have too much problems paying its short term obligations.
COLL has a Current ratio of 1.18. This is in the lower half of the industry: COLL underperforms 77.20% of its industry peers.
A Quick Ratio of 1.10 indicates that COLL should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.10, COLL is not doing good in the industry: 72.02% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 48.19% over the past year.
COLL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 154.78% yearly.
The Revenue has grown by 22.61% in the past year. This is a very strong growth!
Measured over the past years, COLL shows a quite strong growth in Revenue. The Revenue has been growing by 16.31% on average per year.
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
3.2 Future
COLL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.42% yearly.
COLL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.17% yearly.
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.85, the valuation of COLL can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 95.34% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.17, COLL is valued rather cheaply.
COLL is valuated cheaply with a Price/Forward Earnings ratio of 4.51.
Based on the Price/Forward Earnings ratio, COLL is valued cheaper than 96.37% of the companies in the same industry.
COLL is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.85 | ||
| Fwd PE | 4.51 |
4.2 Price Multiples
COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 98.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, COLL is valued cheaper than 95.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.99 | ||
| EV/EBITDA | 4.99 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y4.88%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
38.35
-0.44 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners117.03%
Inst Owner Change-2.57%
Ins Owners1.55%
Ins Owner Change1.21%
Market Cap1.21B
Analysts81.82
Price Target45.49 (18.62%)
Short Float %13.63%
Short Ratio12.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.92%
Min EPS beat(2)1.88%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)3.95%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)9
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-27.3%
Revenue beat(2)2
Avg Revenue beat(2)1.62%
Min Revenue beat(2)1.34%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.9%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)7
Avg Revenue beat(16)-4.84%
PT rev (1m)3.72%
PT rev (3m)4.21%
EPS NQ rev (1m)22.68%
EPS NQ rev (3m)30.36%
EPS NY rev (1m)19.88%
EPS NY rev (3m)19.88%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)2.03%
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)1.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.85 | ||
| Fwd PE | 4.51 | ||
| P/S | 1.71 | ||
| P/FCF | 5.99 | ||
| P/OCF | 5.94 | ||
| P/B | 5.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.99 |
EPS(TTM)6.55
EY17.08%
EPS(NY)8.51
Fwd EY22.18%
FCF(TTM)6.41
FCFY16.71%
OCF(TTM)6.46
OCFY16.84%
SpS22.44
BVpS7.37
TBVpS-22.1
PEG (NY)0.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROCE | 11.5% | ||
| ROIC | 7.69% | ||
| ROICexc | 9.58% | ||
| ROICexgc | N/A | ||
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% | ||
| FCFM | 28.54% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 0.79% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.9 | ||
| Cash Conversion | 59.64% | ||
| Profit Quality | 556.38% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 1.18 |
F-Score5
WACC9.71%
ROIC/WACC0.79
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
EBIT growth 1Y-36.29%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year147.2%
EBIT Next 3Y28.36%
EBIT Next 5Y16.08%
FCF growth 1Y-14.2%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y-13.96%
OCF growth 3Y25.54%
OCF growth 5Y49.12%